SFRP2 and renal pelvis/ureter urothelial carcinoma: Since SFRP2 is specifically expressed in the urinary bladder and the contribution of stromal cell–tumor cell communication to UC progression remained to be determined, we were interested in exploring the role of SFRP2 in UBUC and UTUC, thereby improving prognosis and therapy.